PennTex Midstream Partners (PTXP) Stock Price, News & Analysis

Company Overview

PennTex Midstream Partners, LP, focuses on owning, operating, acquiring and developing midstream energy infrastructure assets in North America. The Company owns and operates midstream gathering, processing and transportation assets in northern Louisiana. The Company provides natural gas gathering and processing and residue gas and natural gas liquid (NGL) transportation services to producers focused on the Cotton Valley formation in northern Louisiana. The Company's assets primarily consisted of natural gas gathering pipeline, two 200 million cubic feet per day (MMcf/d) design-capacity cryogenic natural gas processing plants, and residue gas and NGL transportation pipelines, as of December 31, 2016. In addition to providing midstream services to its primary customer with its existing assets, the Company pursues other opportunities for organic development and growth as producers in its region continue to develop their acreage.

Key Stats

• Today's Range: $20.00 to $20.00
• 50-Day Range: N/A
• 52-Week Range: $14.56 to $20.17
• Volume: N/A
• Average Volume: 163,825 shs
• Market Capitalization: N/A
• P/E Ratio: 14.49
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PTXP Stock Analysis - Frequently Asked Questions

When did PennTex Midstream Partners IPO?

PennTex Midstream Partners (PTXP) raised $226 million in an initial public offering on Thursday, June 4th 2015. The company issued 11,300,000 shares at $19.00-$21.00 per share. Citigroup, Barclays, RBC Capital Markets and Wells Fargo Securities served as the underwriters for the IPO and Deutsche Bank Securities, J.P. Morgan, SunTrust Robinson Humphrey, Tudor, Pickering, Holt & Co., Raymond James, Baird, Stifel and Wunderlich were co-managers.

What other stocks do shareholders of PennTex Midstream Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PennTex Midstream Partners investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), Ampliphi Biosciences (APHB), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX) and Ampio Pharmaceuticals (AMPE).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:PTXP
• CIK: 1617798
• Web: penntex.com
• Phone: +1-713-9897560
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 14.49
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A